Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort

BACKGROUND: Recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) has been a frequent and relevant problem in the past two decades. This analysis evaluated the efficacy and safety of new interferon (IFN)-free direct-acting antiviral (DAA) therapies in a large real-world cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernuth, Sebastian, Grimm, Daniel, Vollmar, Johanna, Darstein, Felix, Mittler, Jens, Heise, Michael, Hoppe-Lotichius, Maria, Galle, Peter R, Lang, Hauke, Zimmermann, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513830/
https://www.ncbi.nlm.nih.gov/pubmed/28744104
http://dx.doi.org/10.2147/DDDT.S139837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513830/
https://www.ncbi.nlm.nih.gov/pubmed/28744104
http://dx.doi.org/10.2147/DDDT.S139837

Ejemplares similares